$1.62B
Revenue
$-9.12M
Net Income
76.74%
Gross Margin
-3.25%
Op. Margin
$343.02M
Free Cash Flow
| Breakdown | Q4 2026 (Jan 31, 2026) |
Q3 2026 (Oct 31, 2025) |
Q2 2026 (Jul 31, 2025) |
Q1 2026 (Apr 30, 2025) |
Q4 2025 (Jan 31, 2025) |
Q3 2025 (Oct 31, 2024) |
Q2 2025 (Jul 31, 2024) |
|---|---|---|---|---|---|---|---|
| Total Revenue | $444.30M | $415.98M | $391.48M | $366.88M | $346.29M | $321.98M | $300.20M |
| Revenue Growth % (YoY) | 28.3% | 29.2% | 30.4% | nan% | nan% | nan% | nan% |
| Cost of Revenue | $105.92M | $96.96M | $90.50M | $83.17M | $80.30M | $76.03M | $73.36M |
| Gross Profit | $338.38M | $319.01M | $300.98M | $283.71M | $265.99M | $245.95M | $226.84M |
| Gross Margin % | 76.2% | 76.7% | 76.9% | 77.3% | 76.8% | 76.4% | 75.6% |
| Operating Expenses | $329.36M | $320.73M | $327.60M | $316.97M | $284.40M | $293.32M | $285.03M |
| Research & Development | $89.52M | $86.22M | $85.61M | $83.24M | $73.28M | $76.99M | $76.48M |
| Operating Income | $9.02M | $-1.72M | $-26.62M | $-33.26M | $-18.41M | $-47.37M | $-58.19M |
| Operating Margin % | 2.0% | -0.4% | -6.8% | -9.1% | -5.3% | -14.7% | -19.4% |
| Other Income/Expense | $18.52M | $10.82M | $11.43M | $12.72M | $9.79M | $10.06M | $9.63M |
| Income Before Tax | $27.54M | $9.10M | $-15.19M | $-20.53M | $-8.62M | $-37.31M | $-48.57M |
| Income Tax Expense | $5.50M | $1.33M | $1.61M | $1.59M | $2.58M | $493.00K | $1.04M |
| Net Income | $22.04M | $7.77M | $-16.80M | $-22.12M | $-11.20M | $-37.81M | $-49.61M |
| Net Margin % | 5.0% | 1.9% | -4.3% | -6.0% | -3.2% | -11.7% | -16.5% |
| Basic EPS | nan | 0.01 | -0.03 | -0.04 | -0.02 | -0.07 | -0.09 |
| Diluted EPS | nan | 0.01 | -0.03 | -0.04 | -0.02 | -0.07 | -0.09 |
| Basic Shares Outstanding | 1.8M | 575.5M | 571.7M | 567.7M | 2.5M | 559.0M | 553.9M |
| Diluted Shares Outstanding | 1.8M | 585.6M | 571.7M | 567.7M | 2.5M | 559.0M | 553.9M |
| Breakdown | Q4 2026 (Jan 31, 2026) |
Q3 2026 (Oct 31, 2025) |
Q2 2026 (Jul 31, 2025) |
Q1 2026 (Apr 30, 2025) |
Q4 2025 (Jan 31, 2025) |
Q3 2025 (Oct 31, 2024) |
Q2 2025 (Jul 31, 2024) |
|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $318.79M | $275.11M | $258.47M | $259.02M | $227.58M | $160.35M | $159.27M |
| Accounts Receivable | $321.44M | $256.68M | $246.08M | $216.47M | $234.02M | $178.72M | $178.79M |
| Inventory | $48.19M | $54.95M | $47.58M | $37.88M | $38.91M | $39.37M | $38.62M |
| Other Current Assets | $69.27M | $52.48M | $63.77M | $57.08M | $58.11M | $34.32M | $38.26M |
| Total Current Assets | $1.51B | $1.26B | $1.19B | $1.13B | $1.15B | $1.04B | $1.04B |
| Property Plant & Equipment | $81.61M | $77.89M | $70.44M | $62.15M | $58.15M | $56.42M | $57.56M |
| Other Non-current Assets | $14.86M | $7.85M | $3.36M | $3.21M | $2.99M | $6.61M | $6.40M |
| Total Assets | $2.54B | $2.31B | $2.21B | $2.07B | $2.02B | $1.86B | $1.83B |
| Accounts Payable | $47.68M | $19.77M | $30.12M | $22.31M | $64.02M | $31.52M | $47.34M |
| Deferred Revenue | $679.32M | $620.85M | $611.31M | $576.55M | $563.25M | $505.56M | $485.91M |
| Total Current Liabilities | $917.04M | $806.39M | $791.59M | $741.16M | $761.35M | $654.12M | $647.16M |
| Other Non-current Liabilities | $13.26M | $7.28M | $7.17M | $7.37M | $6.62M | $8.49M | $9.18M |
| Total Liabilities | $1.12B | $1.01B | $992.33M | $946.04M | $955.11M | $864.73M | $861.46M |
| Retained Earnings | $-1.62B | $-1.64B | $-1.65B | $-1.63B | $-1.61B | $-1.60B | $-1.56B |
| Total Stockholders Equity | $1.42B | $1.30B | $1.21B | $1.13B | $1.07B | $999.13M | $964.68M |
| Total Liabilities & Equity | $2.54B | $2.31B | $2.21B | $2.07B | $2.02B | $1.86B | $1.83B |
| Breakdown | Q4 2026 (Jan 31, 2026) |
Q3 2026 (Oct 31, 2025) |
Q2 2026 (Jul 31, 2025) |
Q1 2026 (Apr 30, 2025) |
Q4 2025 (Jan 31, 2025) |
Q3 2025 (Oct 31, 2024) |
Q2 2025 (Jul 31, 2024) |
|---|---|---|---|---|---|---|---|
| Net Income | $22.04M | $7.77M | $-16.80M | $-22.12M | $-11.20M | $-37.81M | $-49.61M |
| Depreciation & Amortization | $7.43M | $6.08M | $5.40M | $5.14M | $4.80M | $15.85M | $4.63M |
| Stock-based Compensation | $78.93M | $236.06M | $158.21M | $77.08M | $69.02M | $208.85M | $136.26M |
| Change in Receivables | $109.79M | $34.89M | $14.10M | $-15.90M | $52.34M | $23.19M | $20.16M |
| Change in Inventory | $-6.06M | $25.16M | $13.94M | $-1.11M | $2.23M | $20.18M | $18.41M |
| Operating Cash Flow | $69.73M | $166.48M | $102.77M | $52.61M | $53.86M | $77.80M | $41.79M |
| Capital Expenditure | $8.02M | $20.75M | $12.89M | $6.92M | $5.35M | $14.83M | $10.05M |
| Sales of Investments | $183.69M | $530.36M | $348.59M | $161.97M | $129.22M | $472.77M | $305.73M |
| Investing Cash Flow | $-54.82M | $-134.71M | $-86.44M | $-18.29M | $482.00K | $-67.10M | $-33.24M |
| Financing Cash Flow | $12.02M | $17.90M | $18.04M | $-356.00K | $11.49M | $15.61M | $15.98M |
| Net Change in Cash | $28.46M | $50.59M | $35.72M | $35.09M | $65.20M | $25.85M | $23.96M |
SEC Filing Format - Data shown as it appears in the Q3 2026 (10-Q) filing
Period ended: Oct 31, 2025
Condensed Consolidated Statements of Operations
| Description | Oct 31, 2025 | Oct 31, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Total Revenue | $415.98M | $321.98M | $1.17B | $902.91M |
| Cost of Revenue | $96.96M | $76.03M | $270.63M | $218.02M |
| Gross Profit | $319.01M | $245.95M | $903.71M | $684.89M |
| Operating Expenses | $320.73M | $293.32M | $965.30M | $856.45M |
| Research & Development | $86.22M | $76.99M | $255.07M | $226.44M |
| Operating Income | $-1.72M | $-47.37M | $-61.59M | $-171.56M |
| Other Income/Expense | $10.82M | $10.06M | $34.97M | $29.77M |
| Income Before Tax | $9.10M | $-37.31M | $-26.63M | $-141.79M |
| Income Tax Expense | $1.33M | $493.00K | $4.53M | $1.91M |
| Net Income | $7.77M | $-37.81M | $-31.16M | $-143.71M |
| Basic EPS | 0.01 | -0.07 | -0.05 | -0.26 |
| Diluted EPS | 0.01 | -0.07 | -0.05 | -0.26 |
| Basic Shares Outstanding | $575.47M | $559.01M | $571.65M | $553.86M |
| Diluted Shares Outstanding | $585.64M | $559.01M | $571.65M | $553.86M |
Condensed Consolidated Balance Sheets
| Description | Oct 31, 2025 | Jan 31, 2025 |
|---|---|---|
| Cash & Cash Equivalents | $275.11M | $227.58M |
| Accounts Receivable | $256.68M | $234.02M |
| Inventory | $54.95M | $38.91M |
| Other Current Assets | $52.48M | $58.11M |
| Total Current Assets | $1.26B | $1.15B |
| Property Plant & Equipment | $77.89M | $58.15M |
| Other Non-current Assets | $7.85M | $2.99M |
| Total Assets | $2.31B | $2.02B |
| Accounts Payable | $19.77M | $64.02M |
| Deferred Revenue | $620.85M | $563.25M |
| Total Current Liabilities | $806.39M | $761.35M |
| Other Non-current Liabilities | $7.28M | $6.62M |
| Total Liabilities | $1.01B | $955.11M |
| Retained Earnings | $-1.64B | $-1.61B |
| Total Stockholders Equity | $1.30B | $1.07B |
| Total Liabilities & Equity | $2.31B | $2.02B |
Condensed Consolidated Statements of Cash Flows
| Description | Oct 31, 2025 | Oct 31, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Net Income | $7.77M | $-37.81M | $-31.16M | $-143.71M |
| Depreciation & Amortization | $6.08M | $6.76M | $16.62M | $15.85M |
| Stock-based Compensation | - | - | $236.06M | $208.85M |
| Change in Receivables | - | - | $34.89M | $23.19M |
| Change in Inventory | - | - | $25.16M | $20.18M |
| Operating Cash Flow | - | - | $166.48M | $77.80M |
| Capital Expenditure | - | - | $20.75M | $14.83M |
| Sales of Investments | - | - | $530.36M | $472.77M |
| Investing Cash Flow | - | - | $-134.71M | $-67.10M |
| Financing Cash Flow | - | - | $17.90M | $15.61M |
| Net Change in Cash | - | - | $50.59M | $25.85M |
All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-Q filings.
Quarterly data represents single quarter results (Q1-Q4). Some items may show year-to-date values if quarterly breakdown is unavailable.